Navigation Links
ThromboGenics' Microplasmin Phase III Program Progressing According to Schedule
Date:6/24/2009

anti-coagulant, and TB-403 (anti-PlGF) for cancer.

ThromboGenics has built strong links with the University of Leuven and the Flanders Institute for Biotechnology (VIB) and has exclusive rights to certain therapeutics developed at these institutions. ThromboGenics is headquartered in Leuven, Belgium. The Company is listed on Eurolist by Euronext Brussels under the symbol THR. More information is available at http://www.thrombogenics.com.

Important information about forward-looking statements

Certain statements in this press release may be considered "forward-looking". Such forward-looking statements are based on current expectations, and, accordingly, entail and are influenced by various risks and uncertainties. The Company therefore cannot provide any assurance that such forward-looking statements will materialize and does not assume an obligation to update or revise any forward-looking statement, whether as a result of new information, future events or any other reason. Additional information concerning risks and uncertainties affecting the business and other factors that could cause actual results to differ materially from any forward-looking statement is contained in the Company's Annual Report.

    For further information please contact:

    ThromboGenics
    Dr. Steve Pakola, CMO
    Tel: +1-212-201-0920
    steve.pakola@thrombogenics.com

    Dr. Patrik De Haes, CEO
    Tel: +32-16-75-13-10
    patrik.dehaes@thrombogenics.com

    Citigate Dewe Rogerson
    Amber Bielecka/ David Dible/ Nina Enegren
    Tel: +44(0)207-638-95-71
    amber.bielecka@citigatedr.co.uk

'/>"/>
SOURCE ThromboGenics NV
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. ThromboGenics Completes Patient Enrolment in the Phase IIb Trial of Microplasmin in Vitrectomy (MIVI III)
2. ThromboGenics Announces Promising Results of MITI IV Phase II Trial in the Treatment of Acute Stroke with Microplasmin
3. ThromboGenics Begins Phase III Program With Microplasmin for the Non-surgical Treatment of Back of the Eye Disease
4. ThromboGenics and BioInvent Receive Technology Transfer Success Fee From Roche for the Novel Anti-Cancer Antibody, TB-403 (Anti-PIGF)
5. ThromboGenics Completes Patient Enrolment for Phase II Trial of Microplasmin for the Treatment of Diabetic Macular Edema (MIVI II DME)
6. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
7. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
8. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
9. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
10. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
11. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...if., Dec. 1 Codexis, Inc. today an...igning of its second agreement this year with Teva...st generic drug manufacturer. The new agreement c...Codexis announced an earlier agreement with Teva o...ill use Codexis biocatalysis technology for key pr...
(Date:12/1/2009)..., Dec. 1 The global financial cris...for an industry experiencing significant change, a...to drive up the effective tax rate for the phar...to a report released today by PricewaterhouseCoope...ch path will you take? The industry,s response to...
(Date:12/1/2009)... Micromet, Inc. (Nasdaq: ...vel, proprietary antibodies for the treatment of c...announced that Bayer Schering Pharma AG has exerci... license agreement entered into on January 12, 200... of solid tumors. ,, Under the terms of the agr...
Breaking Medicine Technology:Codexis Expands Collaboration with Teva 2Pharmaceutical and Life Sciences Companies Face Rising Tax Rates, Says PricewaterhouseCoopers 2Pharmaceutical and Life Sciences Companies Face Rising Tax Rates, Says PricewaterhouseCoopers 3Pharmaceutical and Life Sciences Companies Face Rising Tax Rates, Says PricewaterhouseCoopers 4Pharmaceutical and Life Sciences Companies Face Rising Tax Rates, Says PricewaterhouseCoopers 5Bayer Schering Exercises Option to Develop Solid Tumor BiTE Antibody with Micromet 2Bayer Schering Exercises Option to Develop Solid Tumor BiTE Antibody with Micromet 3Bayer Schering Exercises Option to Develop Solid Tumor BiTE Antibody with Micromet 4Findings in epilepsy gene in animals may guide treatment directions for infants 47484 1Findings in epilepsy gene in animals may guide treatment directions for infants 47484 2Findings in epilepsy gene in animals may guide treatment directions for infants 47484 3Quality and purity of popular stevia sweetener strengthened by new reference standards 8677 1Quality and purity of popular stevia sweetener strengthened by new reference standards 8677 2Seabrook House Inc Successful in Recession Due to the Acceptance of Most Insurances 3B Expands With New Hires Due to the Growth of the Company 47482 1Seabrook House Inc Successful in Recession Due to the Acceptance of Most Insurances 3B Expands With New Hires Due to the Growth of the Company 47482 2Seabrook House Inc Successful in Recession Due to the Acceptance of Most Insurances 3B Expands With New Hires Due to the Growth of the Company 47482 3
...y Deborah S. Sarnoff, M.D. et al in the February i...plores the new generation of carbon dioxide (CO2) ... the SmartXide DOT(TM) laser. DOT utilizes a frac...kin allowing for rapid healing, less downtime and ...d dermatologist and clinical professor of Dermatol...
...ion- , , -Biologics License Application for Wrink...ed Within Two Weeks- , , , EXTON, Pa., March 5 ...positive top-line efficacy results from a Phase II...en Therapy(TM) for the treatment of moderate to se...y endpoints and was statistically significant, mak...
Other Medicine Technology:New Study Published in the Journal of Drugs in Dermatology Finds DOT Microablative CO2 Laser Optimum for Skin Rejuvenation 2Isolagen, Inc. Reports Positive Top-line Results from Phase II/III Study of Isolagen Therapy(TM) to Treat Moderate to Severe Acne Scars: Study Meets All Primary Efficacy Endpoints and is Statistically Significant 2Isolagen, Inc. Reports Positive Top-line Results from Phase II/III Study of Isolagen Therapy(TM) to Treat Moderate to Severe Acne Scars: Study Meets All Primary Efficacy Endpoints and is Statistically Significant 3Isolagen, Inc. Reports Positive Top-line Results from Phase II/III Study of Isolagen Therapy(TM) to Treat Moderate to Severe Acne Scars: Study Meets All Primary Efficacy Endpoints and is Statistically Significant 4Isolagen, Inc. Reports Positive Top-line Results from Phase II/III Study of Isolagen Therapy(TM) to Treat Moderate to Severe Acne Scars: Study Meets All Primary Efficacy Endpoints and is Statistically Significant 5Isolagen, Inc. Reports Positive Top-line Results from Phase II/III Study of Isolagen Therapy(TM) to Treat Moderate to Severe Acne Scars: Study Meets All Primary Efficacy Endpoints and is Statistically Significant 6
(Date:12/1/2009)...VALLEY, Pa., Dec. 1 Air ...d the previously announced sale of the assets of i...der the Airthane® and Versathane® traden... global polyurethane chemicals producer COIM SpA. ...facturing facility in Paulsboro, N.J. Terms of the...
(Date:12/1/2009)...NIX, Dec. 1 Abrazo Media Relations...osis ( http:// www.pedsorthopaedics.com ) located ...edic surgeon Dr. J. Hunt Udall to its practice. ,...rthopaedic surgery after recently completing his f..., Massachusetts where he focused on adult and pedi...
(Date:12/1/2009)...) The ADEAGies Foundation will honor The Forsyth ... the Gies Awards celebration to be held on Februar... the 2010 ADEA Annual Session & Exhibition. The Wi...chievement recognize contributions to, and support...For a complete listing of Gies Award winners, visi...
(Date:12/1/2009)...gnosis of benign versus cancerous lesions, researc...News) -- When used with ultrasound, elastography h...st lesions, which reduces unnecessary biopsies, U....f breast lesions that are biopsied turn out to be ..., "There,s a lot of room to improve specificity...
(Date:12/1/2009)..., Texas, Dec. 1 For many employers...re is more than just an employee benefit, it,s pro... Hobby Lobby Stores, Inc. is leading this effort, ...health and wellness center at its corporate office...vices directly to employees and their dependents. ...
Breaking Medicine News(10 mins):Health News:Air Products Completes Sale of Polyurethane Pre-Polymers Business to COIM USA 2Health News:Orthopaedic Surgeon Dr. J. Hunt Udall Joins the Center for Pediatric Orthopaedics and Scoliosis as One of Few Trained Doctors to Perform Minimally Invasive Hip Arthroscopy 2Health News:The Forsyth Institute receives the William J. Gies Award for outstanding achievement 2Health News:Ultrasound With Elastography May Cut Down on Biopsies 2Health News:Hobby Lobby Selects Concentra to Open Health Center 2Health News:Hobby Lobby Selects Concentra to Open Health Center 3
...ng to the transport you use. Travelling by taxis r...ng the least. // Research published in the jo...am from Imperial College, London, and the Health a...particles are less than 100 nanometers in diameter...
...mpton in a recent issue of Lancet in which they ha... women who did not have sufficient Vitamin D amoun...developing children’s with low bone density which ... pregnant women, the Vitamin D levels of pregnant ...
... alert even if there is no sound (silence). The br... out for a sound. Pierre Fonlupt and Julien Vo...tional research institute. He studied the brain ac... listen for the possibility of a sound. The p...
...ch at the sleep and Chronobiology Laboratory in th...at mental skills performed immediately after getti... also explains that this is due to the fact that t... This is the time taken by the brain to become act...
...nity with regard to locating a care facility in th...to the Mental Health Council // . The Western Aust...for having reversed the approval given to the 20-b...en called upon to exercise greater tolerance by Ke...
... from McMaster University in their clinical trial ... Antiarrhythmic drugs such as amiodarone combined ...uce the painful shocks in ventricular arrhythmia p...tricular arrhythmias, but these shocks are very pa...
Other Medicine News:Health News:A taxi could increase your exposure to pollution 2Health News:Sleep Inertia Resembles Intoxication 2
...s is a national reference laboratory and a worldwi...velopment. ARUP offers an extensive test menu of h... and anatomic pathology. Owned by the University o...an half of the nation's university teaching hospit...
...s is a national reference laboratory and a worldwi...velopment. ARUP offers an extensive test menu of h... and anatomic pathology. Owned by the University o...an half of the nation's university teaching hospit...
...s is a national reference laboratory and a worldwi...velopment. ARUP offers an extensive test menu of h... and anatomic pathology. Owned by the University o...an half of the nation's university teaching hospit...
...s is a national reference laboratory and a worldwi...velopment. ARUP offers an extensive test menu of h... and anatomic pathology. Owned by the University o...an half of the nation's university teaching hospit...
Medicine Products: